Pub Date : 2013-05-28DOI: 10.1521/CAPN.2013.18.2.1
N. King, D. Reid, Arden D. Dingle
{"title":"Making Ethical Treatment Decisions in ADHD: Psychotropic Medication Use in Child and Adolescent Populations","authors":"N. King, D. Reid, Arden D. Dingle","doi":"10.1521/CAPN.2013.18.2.1","DOIUrl":"https://doi.org/10.1521/CAPN.2013.18.2.1","url":null,"abstract":"","PeriodicalId":89750,"journal":{"name":"Child & adolescent psychopharmacology news","volume":"18 1","pages":"1-4"},"PeriodicalIF":0.0,"publicationDate":"2013-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1521/CAPN.2013.18.2.1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67090313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2013-04-08DOI: 10.1521/CAPN.2013.18.1.1
A. Mao, N. Garber, C. S. Mao
{"title":"Management of Atypical Antipsychotic Induced Prolactin Elevation in Children and Adolescents","authors":"A. Mao, N. Garber, C. S. Mao","doi":"10.1521/CAPN.2013.18.1.1","DOIUrl":"https://doi.org/10.1521/CAPN.2013.18.1.1","url":null,"abstract":"","PeriodicalId":89750,"journal":{"name":"Child & adolescent psychopharmacology news","volume":"18 1","pages":"1-6"},"PeriodicalIF":0.0,"publicationDate":"2013-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1521/CAPN.2013.18.1.1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67090214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2013-04-08DOI: 10.1521/CAPN.2013.18.1.6
Sonal Moratschek, S. Lytle, S. Hatters-friedman
Szarfman, A., Tonning, J., Levine, J., Doraiswamy, P. (2006). Atypical antipsychotics and pituitary tumors: A pharmacovigilance study. Pharmacotherapy, 26, 748-758. Tollin, S. R. (2000).Use of the dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders. Journal of Endocrinological Investigation, 23(11), 765-770.
{"title":"Treatment Considerations During Lactation for Adolescents with Bipolar Disorder","authors":"Sonal Moratschek, S. Lytle, S. Hatters-friedman","doi":"10.1521/CAPN.2013.18.1.6","DOIUrl":"https://doi.org/10.1521/CAPN.2013.18.1.6","url":null,"abstract":"Szarfman, A., Tonning, J., Levine, J., Doraiswamy, P. (2006). Atypical antipsychotics and pituitary tumors: A pharmacovigilance study. Pharmacotherapy, 26, 748-758. Tollin, S. R. (2000).Use of the dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders. Journal of Endocrinological Investigation, 23(11), 765-770.","PeriodicalId":89750,"journal":{"name":"Child & adolescent psychopharmacology news","volume":"18 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2013-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1521/CAPN.2013.18.1.6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67090278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-12-11DOI: 10.1521/CAPN.2012.17.5.5
G. Stout
{"title":"Neutraceuticals and Diet Restriction for the Treatment of Attention-Deficit/Hyperactivity Disorder","authors":"G. Stout","doi":"10.1521/CAPN.2012.17.5.5","DOIUrl":"https://doi.org/10.1521/CAPN.2012.17.5.5","url":null,"abstract":"","PeriodicalId":89750,"journal":{"name":"Child & adolescent psychopharmacology news","volume":"17 1","pages":"5-12"},"PeriodicalIF":0.0,"publicationDate":"2012-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1521/CAPN.2012.17.5.5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67090411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-12-01DOI: 10.1521/CAPN.2012.17.6.1
H. Burton, A. Robb
The physical and psychological symptoms of anorexia nervosa (AN) are intertwined, each affecting each other and each a focus of recovery. Although no FDA approved pharmacotherapy exists for AN, the use of second generation antipsychotics (SGAs) in AN treatment has exponentially increased in the past decade (Fazeli et al., 2012). Frequently, clinicians use SGAs in an attempt to capitalize on the side effects of increased appetite and weight gain often seen with this class of medication. Although it is possible that medication might improve treatment outcomes as part of a multidisciplinary approach initiated during nutritional rehabilitation, there is a lack of data to support pharmacotherapies in this patient population. Recent research has attempted to examine whether (SGAs) are effi cacious for weight restoration in AN. However, the results of research studies thus far are inconsistent and randomized trials looking at outcomes beyond weight increase might better demonstrate the benefi ts of using antipsychotic medication. We will discuss options for future trial designs to test the benefi ts of antipsychotic medications as part of a multidimensional treatment plan.
{"title":"Anorexia Nervosa and Antipsychotics: How to Apply Research Findings to the Adolescent Population","authors":"H. Burton, A. Robb","doi":"10.1521/CAPN.2012.17.6.1","DOIUrl":"https://doi.org/10.1521/CAPN.2012.17.6.1","url":null,"abstract":"The physical and psychological symptoms of anorexia nervosa (AN) are intertwined, each affecting each other and each a focus of recovery. Although no FDA approved pharmacotherapy exists for AN, the use of second generation antipsychotics (SGAs) in AN treatment has exponentially increased in the past decade (Fazeli et al., 2012). Frequently, clinicians use SGAs in an attempt to capitalize on the side effects of increased appetite and weight gain often seen with this class of medication. Although it is possible that medication might improve treatment outcomes as part of a multidisciplinary approach initiated during nutritional rehabilitation, there is a lack of data to support pharmacotherapies in this patient population. Recent research has attempted to examine whether (SGAs) are effi cacious for weight restoration in AN. However, the results of research studies thus far are inconsistent and randomized trials looking at outcomes beyond weight increase might better demonstrate the benefi ts of using antipsychotic medication. We will discuss options for future trial designs to test the benefi ts of antipsychotic medications as part of a multidimensional treatment plan.","PeriodicalId":89750,"journal":{"name":"Child & adolescent psychopharmacology news","volume":"27 1","pages":"1-6"},"PeriodicalIF":0.0,"publicationDate":"2012-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1521/CAPN.2012.17.6.1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67090524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-12-01DOI: 10.1521/CAPN.2012.17.6.7
Kayla Pope
{"title":"The Use of Pharmacological Agents to Treat Aggression: Is It Time to be Thinking about a Mechanism?","authors":"Kayla Pope","doi":"10.1521/CAPN.2012.17.6.7","DOIUrl":"https://doi.org/10.1521/CAPN.2012.17.6.7","url":null,"abstract":"","PeriodicalId":89750,"journal":{"name":"Child & adolescent psychopharmacology news","volume":"17 1","pages":"7-10"},"PeriodicalIF":0.0,"publicationDate":"2012-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1521/CAPN.2012.17.6.7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67090093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-09-18DOI: 10.1521/CAPN.2012.17.4.1
H. Burton, A. Robb
{"title":"CoLT and TEAM: What Do the Results Tell Clinicians about Rational Treatment for Pediatric Bipolar Disorder?","authors":"H. Burton, A. Robb","doi":"10.1521/CAPN.2012.17.4.1","DOIUrl":"https://doi.org/10.1521/CAPN.2012.17.4.1","url":null,"abstract":"","PeriodicalId":89750,"journal":{"name":"Child & adolescent psychopharmacology news","volume":"17 1","pages":"1-8"},"PeriodicalIF":0.0,"publicationDate":"2012-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1521/CAPN.2012.17.4.1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67090183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-09-18DOI: 10.1521/CAPN.2012.17.4.8
Bhavin Dave
Lui, H.Y., Potter, M.P., Woodworth, K.Y., Yorks, D.M., Petty, C.R., Wozniak, J.R., et al. (2011). Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis. Journal of the American Academy of Child & Adolescent Psychiatry, 50, 749-762. Pavuluri, M.N., Henry, D.B., Findling, R.L., Parnes, S., Carbray, J.A., Mohammed, T., et al. (2010). Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder. Bipolar Disorder, 12, 593-605.
{"title":"Rational Use of Medication in Preschool Age Children","authors":"Bhavin Dave","doi":"10.1521/CAPN.2012.17.4.8","DOIUrl":"https://doi.org/10.1521/CAPN.2012.17.4.8","url":null,"abstract":"Lui, H.Y., Potter, M.P., Woodworth, K.Y., Yorks, D.M., Petty, C.R., Wozniak, J.R., et al. (2011). Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis. Journal of the American Academy of Child & Adolescent Psychiatry, 50, 749-762. Pavuluri, M.N., Henry, D.B., Findling, R.L., Parnes, S., Carbray, J.A., Mohammed, T., et al. (2010). Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder. Bipolar Disorder, 12, 593-605.","PeriodicalId":89750,"journal":{"name":"Child & adolescent psychopharmacology news","volume":"17 1","pages":"8-12"},"PeriodicalIF":0.0,"publicationDate":"2012-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1521/CAPN.2012.17.4.8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67090248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-07-13DOI: 10.1521/CAPN.2012.17.3.1
S. Drury, Caitlin Henry
{"title":"Evidenced-Based Treatment of PTSD in Children and Adolescents: Where Does Psychopharmacology Fit?","authors":"S. Drury, Caitlin Henry","doi":"10.1521/CAPN.2012.17.3.1","DOIUrl":"https://doi.org/10.1521/CAPN.2012.17.3.1","url":null,"abstract":"","PeriodicalId":89750,"journal":{"name":"Child & adolescent psychopharmacology news","volume":"17 1","pages":"1-8"},"PeriodicalIF":0.0,"publicationDate":"2012-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1521/CAPN.2012.17.3.1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67090497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：